In the BioHarmony Drug Report Database

"Preview" Icon

Cefixime

Suprax (cefixime) is a small molecule pharmaceutical. Cefixime was first approved as Suprax on 1989-04-28. It is used to treat bacterial infections, bacterial pneumonia, bacterial skin diseases, bronchitis, and escherichia coli infections amongst others in the USA. Suprax’s patent is valid until 2028-12-14 (FDA).

 

Trade Name

 

Suprax
 

Common Name

 

cefixime
 

ChEMBL ID

 

CHEMBL1541
 

Indication

 

bacterial infections, bacterial pneumonia, bacterial skin diseases, bronchitis, escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections, moraxellaceae infections, otitis media, proteus infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Cefixime structure rendering